Impact of Duration of Adjuvant Therapy on Patients with Initially Unresectable Hepatocellular Carcinoma After Conversion Surgery: A Propensity Score Matching Study

Zhong-Tai Lin,1,2,* Shao-Ming Wei,1,3,* Jun-Yi Wu,1,3,* Zhi-Bo Zhang,4 Shuang-Jia Wang,5 Jian-Yin Zhou,6 Meng-Chao Luo,1,3 Zhen-Xin Zeng,1 Xiang-Ye Ou,1 Yang-Kai Fu,1 Han Li,1 De-Yi Liu,1 Jia-Yi Wu,1,3 Mao-Lin Yan1,3 1The Shengli Clinical Medical College of Fujian Medical University, Fuz...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Lin ZT, Wei SM, Wu JY, Zhang ZB, Wang SJ, Zhou JY, Luo MC, Zeng ZX, Ou XY, Fu YK, Li H, Liu DY, Yan ML
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Dove Medical Press 2024-09-01
Ráidu:	Journal of Hepatocellular Carcinoma
Fáttát:	unresectable hepatocellular carcinoma conversion therapy adjuvant therapy recurrence-free survival overall survival
Liŋkkat:	https://www.dovepress.com/impact-of-duration-of-adjuvant-therapy-on-patients-with-initially-unre-peer-reviewed-fulltext-article-JHC
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!